High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency–Associated Genomic Instability in Ovarian Cancer

High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency–Associated Genomic Instability in Ovarian Cancer

Medicine, Medical Laboratory Science, Oncology, Life Sciences, Cell Biology, Biochemistry, Genetics,
Homologous Recombination Deficiency   Ovarian Cancer   Genomic Instability   Biomarkers   PARP Inhibitors  

Ovarian cancer is one of the most common and deadly tumor types in women. In recent years, Poly (ADP-ribose) polymerase inhibitors (PARPi) have shown encouraging clinical results in the treatment of ovarian cancer. Numerous studies have found that patients with homologous recombination deficiency (HRD) benefit more from PARPi treatment. Therefore, ...

Effects of a Combined Exercise and Dietary Intervention on Body Composition, Physical Functioning, and Fatigue in Patients with Ovarian Cancer: Results of the Padova Trial

Effects of a Combined Exercise and Dietary Intervention on Body Composition, Physical Functioning, and Fatigue in Patients with Ovarian Cancer: Results of the Padova Trial

Medicine, Obstetrics and Gynecology, Sports Medicine, Oncology,
Ovarian Cancer   Body Composition   Physical Functioning   Fatigue   Exercise Intervention   Dietary Intervention   Randomized Controlled Trial  

Effects of Combined Exercise and Dietary Intervention on Body Composition, Physical Functioning, and Fatigue in Ovarian Cancer Patients: PADOVA Trial Results Academic Background Ovarian cancer is the seventh most common cancer among women, usually detected at an advanced stage, with an overall 5-year survival rate as low as 30-40%. Standard ovarian...